Frontiers in Drug Research and Development for Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is idiopathic, lifelong, immune-mediated diseases, for which curative therapies are not yet available. In the last 15 years, the introduction of monoclonal antibodies targeting tumor necrosis factor-α, a cytokine playing a key role in bowel inflammation, has revoluti...

Descripción completa

Detalles Bibliográficos
Autores principales: Currò, Diego, Pugliese, Daniela, Armuzzi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481609/
https://www.ncbi.nlm.nih.gov/pubmed/28690543
http://dx.doi.org/10.3389/fphar.2017.00400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481609/
https://www.ncbi.nlm.nih.gov/pubmed/28690543
http://dx.doi.org/10.3389/fphar.2017.00400

Ejemplares similares